Global Prebiotics Industry

Global Prebiotics Industry

  • April 2021 •
  • 312 pages •
  • Report ID: 5379605 •
  • Format: PDF
Abstract:
- Global Prebiotics Market to Reach $9.5 Billion by 2027
- Amid the COVID-19 crisis, the global market for Prebiotics estimated at US$5.2 Billion in the year 2020, is projected to reach a revised size of US$9.5 Billion by 2027, growing at a CAGR of 9% over the analysis period 2020-2027. Fructo-Oligosaccharide (FOS), one of the segments analyzed in the report, is projected to record a 11.2% CAGR and reach US$2.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Inulin segment is readjusted to a revised 8.3% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $1.4 Billion, While China is Forecast to Grow at 15.4% CAGR
- The Prebiotics market in the U.S. is estimated at US$1.4 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.6 Billion by the year 2027 trailing a CAGR of 15.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.3% and 7.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5% CAGR.
- Galacto-Oligosaccharide (GOS) Segment to Record 8.9% CAGR
- In the global Galacto-Oligosaccharide (GOS) segment, USA, Canada, Japan, China and Europe will drive the 8.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$773.8 Million in the year 2020 will reach a projected size of US$1.3 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1.4 Billion by the year 2027, while Latin America will expand at a 9.9% CAGR through the analysis period.

- Select Competitors (Total 69 Featured) -
  • Abbott Nutrition
  • Beghin Meiji S.A.
  • BENEO-Orafti SA
  • Cargill Inc.
  • Clasado Biosciences Ltd.
  • Danone SA
  • DuPont Nutrition & Health
  • Fonterra Co-operative Group Limited
  • Ingredion Inc.
  • Jarrow Formulas, Inc.
  • Kerry Group plc
  • Kirkman Group, Inc.
  • Nestlé S.A.
  • Nexira SAS
  • Royal FrieslandCampina N.V.
  • Weetabix Limited
  • Yakult Pharmaceutical Industry Co., Ltd.